Goldman Sachs
IMGN

Goldman Sachs’s Immunogen Inc IMGN Stock Holding History

Goldman Sachs’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,100
Closed -$10K – 5784
2018
Q3 		$10K Hold
1,100
– – ﹤0.01% 5470
2018
Q2 		$11K Sell
1,100
-1,800
-62% -$19K ﹤0.01% 5540
2018
Q1 		$31K Sell
2,900
-39,900
-93% -$394K ﹤0.01% 5599
2017
Q4 		$274K Sell
42,800
-41,600
-49% -$257K ﹤0.01% 5230
2017
Q3 		$646K Buy
84,400
+64,700
+328% +$430K ﹤0.01% 4909
2017
Q2 		$140K Sell
19,700
-5,700
-22% -$26.1K ﹤0.01% 5983
2017
Q1 		$98K Buy
25,400
+14,900
+142% +$43.5K ﹤0.01% 6072
2016
Q4 		$21K Sell
10,500
-5,600
-35% -$11.2K ﹤0.01% 6633
2016
Q3 		$43K Buy
16,100
+11,600
+258% +$33.7K ﹤0.01% 6532
2016
Q2 		$14K Sell
4,500
-96,600
-96% -$606K ﹤0.01% 6804
2016
Q1 		$861K Buy
+101,100
New +$855K ﹤0.01% 4200
2015
Q4 		– Sell
-2,200
Closed -$21K – 7394
2015
Q3 		$21K Sell
2,200
-56,800
-96% -$830K ﹤0.01% 7024
2015
Q2 		$848K Buy
59,000
+5,400
+10% +$59.3K ﹤0.01% 4685
2015
Q1 		$480K Sell
53,600
-12,200
-19% -$88.4K ﹤0.01% 5172
2014
Q4 		$401K Buy
65,800
+9,100
+16% +$83.2K ﹤0.01% 5488
2014
Q3 		$600K Buy
56,700
+41,600
+275% +$471K ﹤0.01% 5103
2014
Q2 		$179K Sell
15,100
-9,600
-39% -$120K ﹤0.01% 6277
2014
Q1 		$369K Sell
24,700
-7,100
-22% -$112K ﹤0.01% 5561
2013
Q4 		$467K Sell
31,800
-2,500
-7% -$38.4K ﹤0.01% 5343
2013
Q3 		$584K Sell
34,300
-58,000
-63% -$1.02M ﹤0.01% 5045
2013
Q2 		$1.53M Buy
+92,300
New +$1.5M ﹤0.01% 3982

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Goldman Sachs's IMGN Position: Q1 2024 in Review

Goldman Sachs sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,189,485 shares — an estimated $35.3M sold.

Goldman Sachs first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $35.3M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Goldman Sachs reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Goldman Sachs sold 1,189,485 Immunogen Inc shares in Q1 2024, an estimated $35.3M.
  • Goldman Sachs first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Goldman Sachs's Immunogen Inc position peaked at $35.3M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Goldman Sachs's 13F filing for Q1 2024, filed 15 May 2024.